Mode
Text Size
Log in / Sign up

Endovascular thrombectomy boosts functional independence significantly for acute ischemic stroke patients compared to medical management alone

Endovascular thrombectomy boosts functional independence significantly for acute ischemic stroke…
Photo by HI! ESTUDIO / Unsplash
Key Takeaway
Endovascular thrombectomy significantly improves functional independence at 90 days compared to medical management for acute ischemic stroke patients.

This systematic review and meta-analysis evaluated endovascular thrombectomy against medical management for patients with large vessel occlusion. The study included 718 participants to assess functional outcomes at 90 days. Results demonstrated that endovascular thrombectomy significantly improved functional independence compared to standard medical care alone.

The odds ratio for achieving functional independence was 5.38, with a 95% confidence interval of 3.73 to 7.76. This finding was statistically significant with a p-value of 0.0002. The analysis confirmed that the procedure provides substantial benefit for the target patient population.

Subgroup analysis revealed consistent positive results across different collateral flow conditions. Patients with good collaterals showed an odds ratio of 6.09, while those with poor collaterals showed an odds ratio of 8.67. These data suggest the intervention is effective regardless of initial blood flow status.

Limitations include the small number of studies included in the review. Only two trials reported outcomes stratified by collateral status. Despite these constraints, the findings support offering endovascular thrombectomy based on overall clinical and imaging context.

Study Details

Study typeMeta analysis
Sample sizen = 718
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
BACKGROUND: Endovascular thrombectomy (EVT) has transformed acute ischemic stroke (AIS) management due to large vessel occlusion (LVO), markedly improving outcomes within 6 h of symptom onset. The DAWN and DEFUSE-3 trials extended EVT eligibility to 6-24 h, shifting selection from time-based to imaging-based criteria. However, the role of collateral circulation in this extended-window remains uncertain. This study evaluated whether collateral status influences EVT outcomes beyond six hours from symptom onset. METHODS: A systematic review and meta-analysis was conducted per PRISMA guidelines, including randomized controlled trials (RCTs) comparing EVT to medical management in the extended window (6-24 h). Collateral status was categorized as good or poor based on definitions used in the original studies. Eligible studies enrolled AIS patients with LVO and collateral grading. The primary outcome was functional independence (modified Rankin Scale score 0-2 at 90 days). A random-effects model was used to calculate pooled odds ratios (ORs), with subgroup analyses based on collateral status (good vs. poor). RESULTS: Five RCTs involving 718 patients (EVT = 358, medical management = 360) were included. EVT significantly improved functional independence (OR 5.38, 95% CI: 3.73-7.76, P = 0.0002, I = 0%). Only two trials reported outcomes stratified by collateral status (EVT = 142, medical management = 142). EVT improved functional independence in both patients with good collaterals (OR 6.09; P = 0.005) and poor collaterals (OR 8.67; P = 0.04), with no statistically significant difference between subgroups (P = 0.65). CONCLUSION: EVT significantly improves functional independence (mRS 0-2 at 90 days) in extended window (6-24 h) mechanical thrombectomy, and available subgroup data suggest this benefit may extend to both good and poor collaterals. These results support offering EVT based on overall clinical and imaging context. The generalizability of these findings is limited due to the small number of studies. REGISTRATION: This review was not registered in PROSPERO.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.